DR. LUIS DAVID SUMOZA MD NPI 1003258583

NPI Information

  • NPI: 1003258583
  • Provider Name: DR. LUIS DAVID SUMOZA, MD
  • Classification: Internal Medicine - 207RH0000X
  • Specialization: Hematology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 100 NW 170TH ST STE 207
    NORTH MIAMI BEACH, FL
    ZIP 33169
  • Phone: (786) 785-7567

Map and Directions

Get Directions

NPI Details

DR. Luis David Sumoza, MD is a hematology internal medicine in North Miami Beach, FL with 36 years of experience. The provider is an internist with additional training who specializes in diseases of the blood, spleen and lymph. This specialist treats conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma. DR. Luis David Sumoza, MD NPI is 1003258583. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

100 NW 170TH ST STE 207
NORTH MIAMI BEACH, FL
ZIP 33169-510
Phone: (786) 785-7567
Fax: (786) 785-7585

The NPI 1003258583 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Transfusion of blood or blood products (HCPCS:36430)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Unclassified drugs (HCPCS:J3490)
  • Red blood cells, leukocytes reduced, each unit (HCPCS:P9016)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 7/24/2013 and was last updated on 1/23/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME164064FLORIDAYes
2207R00000XInternal Medicine036126207ILLINOISNo
3207RX0202XInternal MedicineMedical OncologyME164064FLORIDANo
4207RX0202XInternal MedicineMedical Oncology036126207ILLINOISNo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1200084858MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.